Michael Bologna Partner and Chief Investment Officer

Mike Bologna, Chief Investment Officer at NovaQuest Capital Management, has over 20 years of experience in the biomedical industry across pharmaceuticals and health care investing. He is a member of the investment committees of the NovaQuest Pharma Opportunities Funds and NovaQuest Animal Health Fund I. As CIO of NovaQuest, he is responsible for the day-to-day investment activities of the firm including oversight of the investment team, Due Diligence and Alliance Management.

He joined the NovaQuest business unit at IQVIA (formerly Quintiles) in 2007 and served as a transaction and due diligence leader. Mr. Bologna had material involvement in the structuring, negotiation, and management of a wide variety of product-based and company investments, prior to the formation of NovaQuest Capital Management in 2010.

Prior to joining NovaQuest, Mr. Bologna served in a variety of roles with EMD Pharmaceuticals (U.S. subsidiary of Merck KGaA) and Eli Lilly and Company. He worked in corporate development, market research, and commercial new product planning.

Mr. Bologna earned a BS in Nursing from University of Michigan and MBA from Fuqua School of Business at Duke University.

The information being provided is strictly as a courtesy. When you link to any of the websites provided here, you are leaving this website. We make no representation as to the completeness or accuracy of information provided at these websites, nor do we assume any risk of using such websites.

Proceed to Link